A new neuromuscular blocking agent: 1-methyl, 1(2-hydroxyethyl) aziridinium tosylate (cyclocholine).
D000818:Animals; D001388:Aziridines / Q000138:chemical synthesis / Q000494:pharmacology*; D001389:Azirines / Q000494:pharmacology*; D001665:Binding Sites / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D002794:Choline / Q000031:analogs & derivatives; D003964:Diaphragm / Q000187:drug effects; D006426:Hemicholinium 3 / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009466:Neuromuscular Blocking Agents; D010791:Phrenic Nerve / Q000187:drug effects; D051381:Rats; D009435:Synaptic Transmission / Q000187:drug effects
D001388:Aziridines; D001389:Azirines; D009466:Neuromuscular Blocking Agents; D006426:Hemicholinium 3; C013457:cyclocholine; D002794:Choline